A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro

We constructed novel HIV-1 fusion inhibitors that may overcome the current limitations of enfuvirtide, the first such therapeutic in this class. The three prototypes generated by the Dock-and-Lock (DNL) technology to comprise four copies of enfuvirtide tethered site-specifically to the Fc end of dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chien-Hsing, Hinkula, Jorma, Loo, Meiyu, Falkeborn, Tina, Li, Rongxiu, Cardillo, Thomas M., Rossi, Edmund A., Goldenberg, David M., Wahren, Britta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402531/
https://www.ncbi.nlm.nih.gov/pubmed/22844444
http://dx.doi.org/10.1371/journal.pone.0041235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402531/
https://www.ncbi.nlm.nih.gov/pubmed/22844444
http://dx.doi.org/10.1371/journal.pone.0041235

Ejemplares similares